{
    "info": {
        "nct_id": "NCT03719690",
        "official_title": "A 2 Cohort, Non-comparative, Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) With HRAS Mutations (AIM-HN) and the Impact of HRAS Mutations on Response to First Line Systemic Therapies for HNSCC (SEQ-HN)",
        "inclusion_criteria": "AIM-HN\n\n1. At least 18 years of age.\n2. Histologically confirmed head and neck cancer (oral cavity, pharynx, larynx, sinonasal, nasopharyngeal, or unknown primary) of squamous histology not amenable to local therapy with curative intent (surgery or radiation therapy with or without chemotherapy).\n3. Documented treatment failure from most recent prior therapy (e.g. tumor progression, clinical deterioration, or recurrence), and from at least one prior platinum-containing regimen, in any treatment setting.\n4. Known tumor missense HRAS mutation.\n5. Measurable disease by RECIST v1.1.\n6. ECOG performance status of 0-1.\n7. Acceptable liver, renal and hematological function\n8. Other protocol defined inclusion criteria may apply.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Histologically confirmed salivary gland, thyroid, (primary) cutaneous squamous or nonsquamous histologies (e.g. mucosal melanoma).\n2. Received treatment for unstable angina within prior year, myocardial infarction within the prior year, cerebro-vascular attack within the prior year, history of New York Heart Association grade III or greater congestive heart failure, or current serious cardiac arrhythmia requiring medication except atrial fibrillation.\n3. Non-tolerable Grade 2 or ≥ Grade 3 neuropathy or evidence of unstable neurological symptoms within 4 weeks of Cycle 1 Day 1.\n4. Active, uncontrolled bacterial, viral or fungal infections requiring systemic therapy. Known history of infection with human immunodeficiency virus or an active infection with hepatitis B or hepatitis C.\n5. Received treatment for non-cancer related liver disease within prior year.\n6. Other protocol defined exclusion criteria may apply\n\nInclusion Criteria: SEQ-HN\n\n1. At least 18 years of age.\n2. Histologically confirmed head and neck cancer (oral cavity, pharynx, larynx, sinonasal, nasopharyngeal, or unknown primary) of squamous histology.\n3. Will or has received at least one systemic anti-cancer therapy for recurrent or metastatic HNSCC.\n4. HRAS wildtype (i.e., have no identified tumor missense HRAS mutation).\n5. Other protocol defined inclusion criteria may apply\n\nExclusion Criteria: SEQ-HN\n\n1. Histologically confirmed salivary gland, thyroid, (primary) cutaneous squamous or nonsquamous histologies (e.g. mucosal melanoma).\n\n5. Other protocol defined exclusion criteria may apply",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "AIM-HN",
            "criterions": [
                {
                    "exact_snippets": "AIM-HN",
                    "criterion": "trial name",
                    "requirements": [
                        {
                            "requirement_type": "identification",
                            "expected_value": "AIM-HN"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. At least 18 years of age.",
            "criterions": [
                {
                    "exact_snippets": "At least 18 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Histologically confirmed head and neck cancer (oral cavity, pharynx, larynx, sinonasal, nasopharyngeal, or unknown primary) of squamous histology not amenable to local therapy with curative intent (surgery or radiation therapy with or without chemotherapy).",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed head and neck cancer (oral cavity, pharynx, larynx, sinonasal, nasopharyngeal, or unknown primary)",
                    "criterion": "head and neck cancer",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": "histologically confirmed"
                        },
                        {
                            "requirement_type": "primary site",
                            "expected_value": [
                                "oral cavity",
                                "pharynx",
                                "larynx",
                                "sinonasal",
                                "nasopharyngeal",
                                "unknown primary"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "squamous histology",
                    "criterion": "histology type",
                    "requirements": [
                        {
                            "requirement_type": "histology",
                            "expected_value": "squamous"
                        }
                    ]
                },
                {
                    "exact_snippets": "not amenable to local therapy with curative intent (surgery or radiation therapy with or without chemotherapy)",
                    "criterion": "amenability to local therapy with curative intent",
                    "requirements": [
                        {
                            "requirement_type": "amenability",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Documented treatment failure from most recent prior therapy (e.g. tumor progression, clinical deterioration, or recurrence), and from at least one prior platinum-containing regimen, in any treatment setting.",
            "criterions": [
                {
                    "exact_snippets": "Documented treatment failure from most recent prior therapy (e.g. tumor progression, clinical deterioration, or recurrence)",
                    "criterion": "treatment failure from most recent prior therapy",
                    "requirements": [
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "failure_type",
                            "expected_value": [
                                "tumor progression",
                                "clinical deterioration",
                                "recurrence"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "treatment failure ... from at least one prior platinum-containing regimen, in any treatment setting",
                    "criterion": "treatment failure from prior platinum-containing regimen",
                    "requirements": [
                        {
                            "requirement_type": "number of regimens",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "regimen"
                            }
                        },
                        {
                            "requirement_type": "regimen type",
                            "expected_value": "platinum-containing"
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Known tumor missense HRAS mutation.",
            "criterions": [
                {
                    "exact_snippets": "Known tumor missense HRAS mutation",
                    "criterion": "tumor HRAS mutation",
                    "requirements": [
                        {
                            "requirement_type": "mutation type",
                            "expected_value": "missense"
                        },
                        {
                            "requirement_type": "status",
                            "expected_value": "known"
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Measurable disease by RECIST v1.1.",
            "criterions": [
                {
                    "exact_snippets": "Measurable disease by RECIST v1.1.",
                    "criterion": "disease",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "assessment_method",
                            "expected_value": "RECIST v1.1"
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. ECOG performance status of 0-1.",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status of 0-1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Acceptable liver, renal and hematological function",
            "criterions": [
                {
                    "exact_snippets": "Acceptable liver ... function",
                    "criterion": "liver function",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "acceptable"
                        }
                    ]
                },
                {
                    "exact_snippets": "Acceptable ... renal ... function",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "acceptable"
                        }
                    ]
                },
                {
                    "exact_snippets": "Acceptable ... hematological function",
                    "criterion": "hematological function",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "acceptable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Other protocol defined inclusion criteria may apply.",
            "criterions": [
                {
                    "exact_snippets": "Other protocol defined inclusion criteria may apply.",
                    "criterion": "other protocol defined inclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "4. HRAS wildtype (i.e., have no identified tumor missense HRAS mutation).",
            "criterions": [
                {
                    "exact_snippets": "HRAS wildtype (i.e., have no identified tumor missense HRAS mutation)",
                    "criterion": "HRAS gene mutation status",
                    "requirements": [
                        {
                            "requirement_type": "mutation status",
                            "expected_value": "wildtype"
                        },
                        {
                            "requirement_type": "missense mutation presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Received treatment for non-cancer related liver disease within prior year.",
            "criterions": [
                {
                    "exact_snippets": "Received treatment for non-cancer related liver disease within prior year.",
                    "criterion": "treatment for non-cancer related liver disease",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Exclusion Criteria: SEQ-HN",
            "criterions": [
                {
                    "exact_snippets": "SEQ-HN",
                    "criterion": "SEQ-HN",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "Inclusion Criteria: SEQ-HN",
            "criterions": [
                {
                    "exact_snippets": "SEQ-HN",
                    "criterion": "SEQ-HN",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Other protocol defined inclusion criteria may apply",
            "criterions": [
                {
                    "exact_snippets": "Other protocol defined inclusion criteria may apply",
                    "criterion": "other protocol defined inclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Active, uncontrolled bacterial, viral or fungal infections requiring systemic therapy. Known history of infection with human immunodeficiency virus or an active infection with hepatitis B or hepatitis C.",
            "criterions": [
                {
                    "exact_snippets": "Active, uncontrolled bacterial, viral or fungal infections requiring systemic therapy",
                    "criterion": "bacterial, viral or fungal infections",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "control",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "treatment_requirement",
                            "expected_value": "systemic therapy"
                        }
                    ]
                },
                {
                    "exact_snippets": "Known history of infection with human immunodeficiency virus",
                    "criterion": "infection with human immunodeficiency virus (HIV)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active infection with hepatitis B or hepatitis C",
                    "criterion": "infection with hepatitis B or hepatitis C",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Received treatment for unstable angina within prior year, myocardial infarction within the prior year, cerebro-vascular attack within the prior year, history of New York Heart Association grade III or greater congestive heart failure, or current serious cardiac arrhythmia requiring medication except atrial fibrillation.",
            "criterions": [
                {
                    "exact_snippets": "Received treatment for unstable angina within prior year",
                    "criterion": "unstable angina",
                    "requirements": [
                        {
                            "requirement_type": "treatment_received_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "myocardial infarction within the prior year",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "event_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "cerebro-vascular attack within the prior year",
                    "criterion": "cerebro-vascular attack",
                    "requirements": [
                        {
                            "requirement_type": "event_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "history of New York Heart Association grade III or greater congestive heart failure",
                    "criterion": "congestive heart failure (NYHA grade)",
                    "requirements": [
                        {
                            "requirement_type": "NYHA_grade",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": ""
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "current serious cardiac arrhythmia requiring medication except atrial fibrillation",
                    "criterion": "serious cardiac arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "current",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "requires_medication",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "exclusion",
                            "expected_value": "atrial fibrillation"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Non-tolerable Grade 2 or ≥ Grade 3 neuropathy or evidence of unstable neurological symptoms within 4 weeks of Cycle 1 Day 1.",
            "criterions": [
                {
                    "exact_snippets": "Non-tolerable Grade 2 or ≥ Grade 3 neuropathy",
                    "criterion": "neuropathy",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": [
                                "non-tolerable Grade 2",
                                ">= Grade 3"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "evidence of unstable neurological symptoms within 4 weeks of Cycle 1 Day 1",
                    "criterion": "unstable neurological symptoms",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "weeks before Cycle 1 Day 1"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. At least 18 years of age.",
            "criterions": [
                {
                    "exact_snippets": "At least 18 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Will or has received at least one systemic anti-cancer therapy for recurrent or metastatic HNSCC.",
            "criterions": [
                {
                    "exact_snippets": "Will or has received at least one systemic anti-cancer therapy for recurrent or metastatic HNSCC.",
                    "criterion": "systemic anti-cancer therapy for recurrent or metastatic HNSCC",
                    "requirements": [
                        {
                            "requirement_type": "history of receipt",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "therapy"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Histologically confirmed salivary gland, thyroid, (primary) cutaneous squamous or nonsquamous histologies (e.g. mucosal melanoma).",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed salivary gland",
                    "criterion": "salivary gland cancer",
                    "requirements": [
                        {
                            "requirement_type": "histology confirmation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Histologically confirmed ... thyroid",
                    "criterion": "thyroid cancer",
                    "requirements": [
                        {
                            "requirement_type": "histology confirmation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Histologically confirmed ... (primary) cutaneous squamous ... histologies",
                    "criterion": "primary cutaneous squamous histology",
                    "requirements": [
                        {
                            "requirement_type": "histology confirmation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Histologically confirmed ... (primary) cutaneous ... nonsquamous histologies (e.g. mucosal melanoma)",
                    "criterion": "primary cutaneous nonsquamous histology",
                    "requirements": [
                        {
                            "requirement_type": "histology confirmation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Other protocol defined exclusion criteria may apply",
            "criterions": [
                {
                    "exact_snippets": "Other protocol defined exclusion criteria may apply",
                    "criterion": "other protocol defined exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Histologically confirmed head and neck cancer (oral cavity, pharynx, larynx, sinonasal, nasopharyngeal, or unknown primary) of squamous histology.",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed head and neck cancer",
                    "criterion": "head and neck cancer",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": "histologically confirmed"
                        }
                    ]
                },
                {
                    "exact_snippets": "oral cavity, pharynx, larynx, sinonasal, nasopharyngeal, or unknown primary",
                    "criterion": "primary tumor site",
                    "requirements": [
                        {
                            "requirement_type": "location",
                            "expected_value": [
                                "oral cavity",
                                "pharynx",
                                "larynx",
                                "sinonasal",
                                "nasopharyngeal",
                                "unknown primary"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "squamous histology",
                    "criterion": "tumor histology",
                    "requirements": [
                        {
                            "requirement_type": "histology type",
                            "expected_value": "squamous"
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Other protocol defined exclusion criteria may apply",
            "criterions": [
                {
                    "exact_snippets": "Other protocol defined exclusion criteria may apply",
                    "criterion": "other protocol defined exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Histologically confirmed salivary gland, thyroid, (primary) cutaneous squamous or nonsquamous histologies (e.g. mucosal melanoma).",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed salivary gland",
                    "criterion": "salivary gland cancer",
                    "requirements": [
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Histologically confirmed ... thyroid",
                    "criterion": "thyroid cancer",
                    "requirements": [
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Histologically confirmed ... (primary) cutaneous squamous ... histologies",
                    "criterion": "primary cutaneous squamous histology",
                    "requirements": [
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Histologically confirmed ... nonsquamous histologies (e.g. mucosal melanoma)",
                    "criterion": "nonsquamous histology (e.g. mucosal melanoma)",
                    "requirements": [
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}